Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.3.1.900
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Net revenue $ 106,000 $ 210,000 $ 277,000 $ 296,000
Cost of sales 202,000 193,000 440,000 272,000
Gross (loss) profit (96,000) 17,000 (163,000) 24,000
Operating expenses:        
Selling and administrative expenses 597,000 474,000 1,152,000 949,000
Amortization of prepaid advisory fees 8,000 1,000 12,000 33,000
Research and development 469,000 141,000 801,000 262,000
Total operating expenses 1,074,000 616,000 1,965,000 1,244,000
Operating loss (1,170,000) (599,000) (2,128,000) (1,220,000)
Other income (expense):        
Change in fair value of derivative liabilities 0 0 0 438,000
Interest expense, net (46,000) (23,000) (96,000) (23,000)
Other income (expense) 0 4,000 0 (10,000)
Net loss $ (1,216,000) $ (618,000) $ (2,224,000) $ (815,000)
Net loss per share - basic and diluted $ (0.01) $ (0.01) $ (0.02) $ (0.01)
Weighted average number of common shares outstanding - basic and diluted 150,825,082 97,399,546 132,681,921 95,628,315